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Abstract
Introduction: Transcatheter arterial chemoembolization has been widely used to treat advanced
hepatocellular carcinoma that cannot be treated by local ablation therapies or surgical resection. The
effectiveness of transcatheter arterial chemoembolization in prolonging survival has been well
established, and approximately one third of newly discovered hepatocellular carcinoma patients were
repeatedly treated by transcatheter arterial chemoembolization in Japan. Various kinds of
complications have been reported, and many of which are general complications such as hepatic
coma, jaundice, fever-up, ascites, and bile duct injury.
The hepatic falciform artery is found frequently during postmortem anatomic dissection and the
incidence of hepatic falciform artery is reported to be over 60%. Hepatic falciform artery is known to
be the responsible artery for supraumbilical skin rash development after arterial chemo infusion
therapy; however, skin complications after transcatheter arterial chemoembolization are rare.
Case presentation: A 70-year-old female with chronic hepatitis C infection was diagnosed as
having hepatocellular carcinoma (S4, 20 mm in diameter). Transcatheter arterial chemoembolization
was performed via the left hepatic artery, which was a feeding artery of the hepatocellular carcinoma.
Two days after that, supraumbilical skin rash with local tenderness and redness appeared.
Retrospective analysis revealed that occlusion of the hepatic falciform artery branching from the left
hepatic artery with micromaterials caused the skin lesion.
Conclusion: We should keep in mind that anticancer drugs or embolic materials can flow into the
HFA and may cause abdominal wall injury after transcatheter arterial chemoembolization.
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A 70-year-old Japanese female (Asian) had suffered from
chronic hepatitis C since 1992. In March 2006, hepato-
cellular carcinoma (HCC) (20 mm in diameter) was found
inliversegment4,andshewasadmittedtoourhospital.She
had a history of tuberculosis of the lymph nodes in 1992.
Laboratory findings on admission were as follows: white
blood cell count 1.77 × 1000/mm
3, red blood cell count
339 × 104/mm
3, hemoglobin 11.3 g/dL, hematocrit
31.9%, platelet count 3.1 × 10000/mm
3, total protein
7.3g/dL,albumin3.5g/dL,totalbilirubin1.7mg/dL,direct
bilirubin 0.7 mg/dL, aspartate aminotransferase 68 IU/L,
alanine aminotransferase 35 IU/L, alkaline phosphatase
402 IU/L, g-glutamyltranspeptidase 13 IU/L, cholinesterase
108 IU/L, total cholesterol 137 mg/dL, blood urea nitrogen
16 mg/dL, Creatinine 0.7 mg/dL, Na 142.5 mEq/L,
K 3.0 mEq/L, Cl 110.2 mEq/L, Ca 8.8 mg/dL, prothrombin
time63.8%,ICG-R33.8%,ICG-K0.072,des-gamma-carboxy
prothrombin 325 mAU/mL, and alpha-fetoprotein
6.8 ng/mL. The patient was positive for HCV antibody but
negative for hepatitis B virus surface antigen.
Enhancement in the early phase and perfusion defect in
the delayed phase were observed in segment 4 (20 mm in
diameter) of the liver by computed tomography, and
collateral veins were also noted (Figure 1). The tumor
findings by abdominal ultrasonography were typical of
HCC, which was a hyperechoic space occupied by a lesion
with hallow. Hepatic arteriography showed tumor staining
in the delayed phase, and the feeder of the lesion was A4
(artery 4). Lipiodol (2 ml) mixed with epirubicin (12 mg)
followed by gelatin sponge was injected via the left hepatic
artery, and A4 was completely occluded.
Soon after Transcatheter arterial chemoembolization
(TACE), she complained of epigastric pain, and a skin
rash appeared on the upper abdominal wall on day 2
(Figure 2). Angiography was retrospectively re-evaluated.
The HFA branching from the left hepatic artery was faintly
observed in the early arterial phase, and the flow persisted
until the delayed phase (Figure 3). After TACE, hepatic
falciform artery (HFA) had completely disappeared. The
area of the skin lesion was consistent with the perfusion
area of theHFA,so thatinflow of theanticancer drugto the
HFA and its subsequent occlusion were presumed to be
the cause of the skin rash.
We injected steroid in the site on day 3 and 7, and
prescribed tranilast (anti-allergic agent). At 5 days after
TACE,theskinrashandpainresolved,andpurplespotsand
hard subcutaneous nodules emerged on day 7 (Figure 4).
Ten months later, the skin rash had completely healed.
Discussion
The HFA arises as a small terminal branch of the left or
middle hepatic artery, runs through the hepatic falciform
ligament, distributes itself around the umbilicus, and
communicates with branches of the superior and inferior
epigastric arteries [7-13]. Michels et al. reported that the
HFA is found frequently during postmortem anatomic
Figure 1. Axial computed tomography image with contrast
enhancement before angiography. Classical HCC (20 mm) was
observed in segment 4 (arrows). Collateral veins were seen
along the abdominal wall (arrow heads). A; Early phase. B;
Delayed phase.
Figure 2. Skin lesion at 3 days after TACE. The patient
complained of epigastric pain soon after TACE, and the pain
persisted for 5 days. Skin redness appeared on the upper
abdominal wall on day 2.
Figure 3. (A) Arterial phase of the left hepatic arteriogram
showing a dilated falciform artery (arrows) arising from the
left hepatic artery. (B) In the delayed phase, the flow
persisted, and HCC staining was clearly detected in segment 4.
(C) The HFA shadow completely disappeared after TACE.
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58 patients (67.2%) [13]. There are some reports on skin
complications in angiography caused by the inflow of
anti-cancer drugs or occlusion materials to HFA [7-12].
The complication is rare and does not necessarily occur in
all cases with HFA. However, once skin injury has
occurred, it is sometimes severe enough to require
debridement. Therefore, we should always pay attention
to the artery during transcatheter arterial treatments.
There are two major factors concerning skin injury due to
transcatheter therapies. One is the size of the occlusion
material: small particles like Lipiodol sometimes embolize
the perfusion area completely [11-12]. The other is the
duration of chemotherapeutic agents: continuous arterial
injection of anti-cancer drugs is known to induce skin
injury [10]. We used Lipiodol mixed with epirubicin, and
the dose was the same as we routinely use, so that the
reason for the skin lesion seems different from the two
reported factors. It isknown thatportal hypertension anda
decrease in portal vein flow cause a compensatory increase
of hepatic arterial flow and the development of portal
collateral vessels [7]. Our case showed severe collateral
vein accompanied by portal hypertension. Therefore, it is
possible that HFA (collateral vein) flow increased, and the
volume of chemical micromaterials flowing into the HFA
was enhanced, resulting in skin injury.
While high incidence of HFA (67.2%) was reported on
postmortem anatomic dissections, the reported incidences
of HFA on angiography were low (ranging from 2% to
24.5%) [7-9]. One of the reasons for these discrepancies
seems to be the velocity of arterial flow. The flow was often
too slow to be regularly detected during the early arterial
phase on angiography [9]. The similarity of the HFA route
withthoseofotherarteriesmightbeanotherreason.TheHFA
runs close to the hepatic artery, cystic artery, and gastro-
duodenal artery, so that it is easy to misinterpret the HFA.
There are controversies with regard to the relationship
between the HFA and the hepatic disease state. Kim et al.
reported that patients with anHFA had significantly higher
serum bilirubin levels, lower albumin levels, and longer
prothrombin times than patients without one. Chung
et al. reported that portal vein collateral vessels were more
frequently observed in patients with HFA presence than
absence [6]. Conversely, Gibo et al. reported no significant
difference in HFA incidence between a chronic liver
disease group and normal liver group [8]. Although the
mechanism of the skin injury in our case can be explained
by Chung’s report, further study is needed to reach a
conclusion regarding these discrepancies.
For the prevention of skin rash, it is reasonable to perform
TACE by placing the tip of the microcatheter beyond the
origin of the HFA, or embolization of the HFA with
microcoils or gelatin sponge prior to TACE. Because the
HFA often communicates with branches of inferior and
superior epigastric arteries, the skin lesion does not occur
when embolizing the HFA with micro coils or simple
gelatin sponge particles [8-12]. Hence, it is reasonable to
consider embolizing the HFA with micro coils to prevent
such a complication, especially in cases with severe portal
hypertension or undergoing long-term chemotherapy with
a reserved microcatheter, in which the drug volume needs
to be increased.
In conclusion, we should keep in mind that anticancer
drugs or embolic materials can flow into the HFA and may
cause abdominal wall injury after TACE.
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